---
layout: default
title: Research - AlphaFold3
permalink: /research/ai/alphafold3/
---

<style>
  /* 保持原有样式不变 */
  .af3-hero {
    background: linear-gradient(135deg, #3498db 0%, #2980b9 100%);
    color: white;
    padding: 80px 20px;
    text-align: center;
    margin: -40px -40px 60px -40px;
    position: relative;
    overflow: hidden;
  }

  .af3-hero::before {
    content: '';
    position: absolute;
    top: 0;
    left: 0;
    right: 0;
    bottom: 0;
    background: url('data:image/svg+xml,<svg width="100" height="100" xmlns="http://www.w3.org/2000/svg"><path d="M10,50 Q50,10 90,50 T170,50" stroke="white" fill="none" stroke-width="1" opacity="0.1"/></svg>');
    animation: float 25s linear infinite;
  }

  @keyframes float {
    from { background-position: 0 0; }
    to { background-position: 100px 100px; }
  }

  .af3-hero h1 {
    font-size: 3.5em;
    font-weight: 800;
    margin-bottom: 20px;
    position: relative;
    z-index: 1;
  }

  .af3-hero .tagline {
    font-size: 1.4em;
    opacity: 0.95;
    max-width: 700px;
    margin: 0 auto;
    position: relative;
    z-index: 1;
  }

  .af3-container {
    max-width: 1200px;
    margin: 0 auto;
    padding: 0 20px;
  }

  .section {
    margin-bottom: 80px;
  }

  .section-title {
    font-size: 2.2em;
    font-weight: 700;
    color: #2c3e50;
    margin-bottom: 30px;
    border-left: 5px solid #2980b9;
    padding-left: 20px;
  }

  .features-grid {
    display: grid;
    grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
    gap: 30px;
    margin-top: 40px;
  }

  .feature-card {
    background: white;
    padding: 30px;
    border-radius: 12px;
    box-shadow: 0 4px 20px rgba(0,0,0,0.08);
    transition: all 0.3s;
    border-top: 3px solid #2980b9;
  }

  .feature-card:hover {
    transform: translateY(-5px);
    box-shadow: 0 8px 30px rgba(41, 128, 185, 0.15);
  }

  .feature-icon {
    font-size: 2.5em;
    margin-bottom: 15px;
  }

  .feature-card h3 {
    color: #2c3e50;
    font-size: 1.4em;
    margin-bottom: 15px;
  }

  .feature-card p {
    color: #666;
    line-height: 1.7;
  }

  .stats-bar {
    display: flex;
    justify-content: space-around;
    flex-wrap: wrap;
    background: #f8f9fa;
    padding: 40px 20px;
    border-radius: 12px;
    margin: 40px 0;
  }

  .stat-item {
    text-align: center;
    padding: 20px;
  }

  .stat-number {
    font-size: 3em;
    font-weight: 800;
    color: #2980b9;
    display: block;
  }

  .stat-label {
    color: #666;
    font-size: 1.1em;
    margin-top: 10px;
  }

  .workflow-diagram {
    background: white;
    padding: 40px;
    border-radius: 12px;
    box-shadow: 0 4px 20px rgba(0,0,0,0.08);
    margin: 40px 0;
  }

  .workflow-step {
    display: flex;
    align-items: center;
    margin-bottom: 30px;
    padding: 20px;
    background: #f8f9fa;
    border-radius: 8px;
    border-left: 4px solid #2980b9;
  }

  .step-number {
    font-size: 2em;
    font-weight: 800;
    color: #2980b9;
    min-width: 60px;
  }

  .step-content h4 {
    color: #2c3e50;
    margin-bottom: 8px;
  }

  .step-content p {
    color: #666;
    margin: 0;
  }

  .cta-section {
    background: linear-gradient(135deg, #2980b9 0%, #3498db 100%);
    color: white;
    padding: 60px 40px;
    border-radius: 12px;
    text-align: center;
    margin-top: 60px;
  }

  .cta-section h2 {
    font-size: 2.5em;
    margin-bottom: 20px;
  }

  .cta-buttons {
    display: flex;
    gap: 20px;
    justify-content: center;
    margin-top: 30px;
    flex-wrap: wrap;
  }

  .cta-btn {
    padding: 15px 40px;
    border-radius: 30px;
    text-decoration: none;
    font-weight: 600;
    font-size: 1.1em;
    transition: all 0.3s;
    display: inline-block;
  }

  .cta-btn-primary {
    background: white;
    color: #2980b9;
  }

  .cta-btn-primary:hover {
    transform: translateY(-3px);
    box-shadow: 0 10px 30px rgba(255,255,255,0.3);
  }

  .cta-btn-secondary {
    background: transparent;
    color: white;
    border: 2px solid white;
  }

  .cta-btn-secondary:hover {
    background: white;
    color: #2980b9;
  }

  @media (max-width: 768px) {
    .af3-hero h1 {
      font-size: 2.5em;
    }
    .features-grid {
      grid-template-columns: 1fr;
    }
  }
</style>

<!-- Hero区域 -->
<div class="af3-hero">
  <h1>🧬 AlphaFold3</h1>
  <p class="tagline">Advanced Protein Structure Prediction<br>Focus on Therapeutic Targets</p>
</div>

<div class="af3-container">

  <!-- 项目概述 -->
  <div class="section">
    <h2 class="section-title">Project Overview</h2>
    <p style="font-size: 1.15em; line-height: 1.8; color: #555;">
      AlphaFold3 represents a breakthrough in protein structure prediction, extending beyond individual proteins
      to model complex assemblies and dynamic conformations. Our research focuses specifically on applying this
      revolutionary technology to solve the structures of key therapeutic targets—including those involved in
      influenza, cancer, bacterial infections, and flaviviruses like dengue virus (DENV)—that serve as critical drug targets for major human diseases.
    </p>
  </div>

  <!-- 统计数据 -->
  <div class="stats-bar">
    <div class="stat-item">
      <span class="stat-number">98%</span>
      <span class="stat-label">Prediction Accuracy (RMSD)</span>
    </div>
    <div class="stat-item">
      <span class="stat-number">52+</span>
      <span class="stat-label">Therapeutic Targets Modeled</span>
    </div>
    <div class="stat-item">
      <span class="stat-number">10μs</span>
      <span class="stat-label">MD Simulation Data</span>
    </div>
    <div class="stat-item">
      <span class="stat-number">38</span>
      <span class="stat-label">Novel Binding Sites Identified</span>
    </div>
  </div>

  <!-- 核心技术 -->
  <div class="section">
    <h2 class="section-title">Core Technologies</h2>
    <div class="features-grid">
      <div class="feature-card">
        <div class="feature-icon">🔮</div>
        <h3>Structure Prediction</h3>
        <p>Improved attention mechanisms for modeling disulfide bonds, ligand interactions, and conformational variations in therapeutic targets, including viral envelope proteins from flaviviruses.</p>
      </div>

      <div class="feature-card">
        <div class="feature-icon">🔄</div>
        <h3>Conformational Dynamics</h3>
        <p>Integration with molecular dynamics simulations to capture activation/inhibition transitions and flexibility hotspots in disease-related proteins, including viral maturation processes.</p>
      </div>

      <div class="feature-card">
        <div class="feature-icon">🧩</div>
        <h3>Complex Assembly</h3>
        <p>Modeling of protein-drug complexes and multi-protein assemblies critical for disease progression and treatment response, including virus-host protein interactions.</p>
      </div>

      <div class="feature-card">
        <div class="feature-icon">🩺</div>
        <h3>Variant Analysis</h3>
        <p>Structural impact prediction of mutations in drug targets and resistance-associated variants in cancer, microbial pathogens, and flavivirus strains.</p>
      </div>

      <div class="feature-card">
        <div class="feature-icon">💊</div>
        <h3>Docking Compatibility</h3>
        <p>High-precision active site modeling enabling structure-based drug design for targeted therapeutics and antimicrobials, including antiviral compounds against flaviviruses.</p>
      </div>

      <div class="feature-card">
        <div class="feature-icon">📊</div>
        <h3>Structural Alignments</h3>
        <p>Comparative analysis tools for identifying conserved features and divergent regions across therapeutic target families, including viral proteins from related flaviviruses.</p>
      </div>
    </div>
  </div>

  <!-- 治疗靶点研究 -->
  <div class="section">
    <h2 class="section-title">Therapeutic Target Research</h2>
    <div class="features-grid">
      <div class="feature-card">
        <h3>🦟 Influenza Virus Proteins</h3>
        <p>Structural characterization of neuraminidase and hemagglutinin variants, including drug-resistant strains and seasonal variants.</p>
      </div>

      <div class="feature-card">
        <h3>🔬 Cancer Oncoproteins</h3>
        <p>Modeling of kinase signaling proteins and transcription factors with hotspot mutations driving tumorigenesis and metastasis.</p>
      </div>

      <div class="feature-card">
        <h3>🦠 Antimicrobial Targets</h3>
        <p>Structural insights into bacterial cell wall synthesis enzymes and viral replication machinery for novel antibiotic development.</p>
      </div>

      <div class="feature-card">
        <h3>🎯 Cancer Biomarkers</h3>
        <p>Comparative analysis revealing conserved binding pockets in tumor-specific antigens across different cancer types.</p>
      </div>

      <div class="feature-card">
        <h3>🦟 DENV & Flaviviruses</h3>
        <p>Structural modeling of envelope (E) proteins, NS3 protease, and NS5 polymerase from dengue virus serotypes, Zika, West Nile, and yellow fever viruses.</p>
      </div>

      <div class="feature-card">
        <h3>🔍 Viral-Host Interactions</h3>
        <p>Prediction of flavivirus protein interactions with host cell receptors (e.g., DENV E protein with human CLEC5A) and antiviral factors.</p>
      </div>
    </div>
  </div>

  <!-- 工作流程 -->
  <div class="section">
    <h2 class="section-title">Analysis Pipeline</h2>
    <div class="workflow-diagram">
      <div class="workflow-step">
        <div class="step-number">01</div>
        <div class="step-content">
          <h4>Sequence Acquisition</h4>
          <p>Retrieve and curate target protein sequences from NCBI, UniProt, and disease-specific databases, including flavivirus genomic data.</p>
        </div>
      </div>

      <div class="workflow-step">
        <div class="step-number">02</div>
        <div class="step-content">
          <h4>Structure Prediction</h4>
          <p>Generate high-confidence models using AlphaFold3 with custom parameters optimized for therapeutic targets, including viral proteins with dynamic conformations.</p>
        </div>
      </div>

      <div class="workflow-step">
        <div class="step-number">03</div>
        <div class="step-content">
          <h4>Model Validation</h4>
          <p>Validate predictions against existing cryo-EM and X-ray structures using RMSD, TM-score, and active site geometry analysis.</p>
        </div>
      </div>

      <div class="workflow-step">
        <div class="step-number">04</div>
        <div class="step-content">
          <h4>Dynamic Simulation</h4>
          <p>Perform molecular dynamics simulations to explore conformational landscapes and identify functionally relevant states.</p>
        </div>
      </div>

      <div class="workflow-step">
        <div class="step-number">05</div>
        <div class="step-content">
          <h4>Functional Annotation</h4>
          <p>Identify active sites, binding pockets, and allosteric regions using structural bioinformatics tools.</p>
        </div>
      </div>

      <div class="workflow-step">
        <div class="step-number">06</div>
        <div class="step-content">
          <h4>Therapeutic Targeting</h4>
          <p>Map druggable sites and generate structure-based pharmacophores for drug development.</p>
        </div>
      </div>
    </div>
  </div>

  <!-- 研究应用 -->
  <div class="section">
    <h2 class="section-title">Research Applications</h2>
    <div style="background: #f8f9fa; padding: 40px; border-radius: 12px;">
      <ul style="font-size: 1.1em; line-height: 2; color: #555;">
        <li><strong>Antiviral Development:</strong> Structure-guided design of influenza inhibitors, broad-spectrum antiviral agents, and flavivirus (DENV/Zika) therapeutics</li>
        <li><strong>Cancer Therapy:</strong> Development of targeted inhibitors for oncogenic proteins and signaling pathways</li>
        <li><strong>Antimicrobial Discovery:</strong> Identification of novel antibacterial targets to combat drug resistance</li>
        <li><strong>Flavivirus Vaccine Design:</strong> Structural analysis of DENV envelope proteins to identify conserved neutralizing epitopes across serotypes</li>
        <li><strong>Personalized Medicine:</strong> Structural analysis of patient-specific mutations for tailored therapies</li>
        <li><strong>Drug Repurposing:</strong> Identification of existing drugs that can target new therapeutic proteins</li>
        <li><strong>Vaccine Development:</strong> Structural epitope identification for cancer vaccines and antiviral immunogens</li>
      </ul>
    </div>
  </div>

  <!-- 合作机会 -->
  <div class="cta-section">
    <h2>Collaborate on Therapeutic Research</h2>
    <p style="font-size: 1.2em; opacity: 0.95; max-width: 700px; margin: 0 auto;">
      We're seeking partnerships with research labs, pharmaceutical companies, and healthcare organizations
      to apply AlphaFold3 for drug discovery and therapeutic development across influenza, cancer, infectious diseases, and flaviviruses like DENV.
    </p>
    <div class="cta-buttons">
      <a href="/contact/" class="cta-btn cta-btn-primary">Collaborate Now</a>
      <a href="/publications/" class="cta-btn cta-btn-secondary">View Publications</a>
    </div>
  </div>

</div>